Associate Director, Material Management

Overview The Associate Director, Material Management will be responsible for the site planning of cell therapy materials used in the facility. You will oversee all materials planning processes to support on-time delivery to patients. Responsibilities Set up and oversee site materials planning processes and systems including assumptions management, Bill of Materials, inventory policy, master data, inventory management Establish people, process and systems capabilities for materials planning Develop Materials Planner planning cycle standard work and tools in alignment with S&OP Develop metrics reporting on supply, inventory, scrap, expiry across the network Participate and provide inputs to site S&OE process Support supplier strategies and forecasting Manage change and variations management from introduction of new materials, second suppliers, tech transfers, and process improvements Collaborate with Global Material Planning and Purchasing for execution and follow-up of purchase orders to suppliers Analyze trends to develop and implement materials planning process improvements Mature systems and process capabilities for inventory planning Essential Skills/Experience Knowledgeable with cGxP and regulatory regulations and compliance requirements for cell therapy and pharmaceutical industry High proficiency in ERP (SAP preferred) and Planning Systems High proficiency in Microsoft Excel; experience with advanced functions and data analysis is a plus Experience managing a team of direct reports Excellent analytical and problem-solving skills Excellent communication and interpersonal skills to foster effective collaboration with internal teams and external suppliers Professional certifications like CPIM or APICS are a plus Required Education And Experience 10+ years with BS/BA, or 8+ years with MS/MA or MBA Direct experience and working knowledge in planning, materials requirements planning, production scheduling in the pharmaceutical or biotech industry, cell therapy preferred #J-18808-Ljbffr AstraZeneca